Astex Therapeutics Limited, registered in England and Wales with registration number 03751674, was established in 1999 and remains an active limited company. The company’s registered office is located at 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA. Astex Therapeutics operates as a research and experimental development company focused on biotechnology. Based on website information, the company size is not specified, but its activities align with a research-oriented operation. Astex Therapeutics utilizes free company information from Companies House to provide details regarding its filings, accounts, and officers. Financial records indicate accounts were prepared for the period ending 2024-12-31, with no outstanding charges and the company is not insolvent. The company’s primary industry classification under the SIC 72110 code is ‘None’. Astex Therapeutics does not appear to have an international presence. It does not exhibit hiring indicators based on available website data. Regarding visa information, Astex Therapeutics holds a Global Business Mobility visa, specifically a ‘Worker (A rating)’. This suggests the company engages in activities that qualify for this visa category. The company’s core business revolves around biotechnology research and development, as indicated by its stated focus.

Astex Therapeutics Limited, registered in England and Wales with registration number 03751674, was established in 1999 and remains an active limited company. The company’s registered office is located at 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA. Astex Therapeutics operates as a research and experimental development company focused on biotechnology. Based on website information, the company size is not specified, but its activities align with a research-oriented operation. Astex Therapeutics utilizes free company information from Companies House to provide details regarding its filings, accounts, and officers. Financial records indicate accounts were prepared for the period ending 2024-12-31, with no outstanding charges and the company is not insolvent. The company’s primary industry classification under the SIC 72110 code is ‘None’. Astex Therapeutics does not appear to have an international presence. It does not exhibit hiring indicators based on available website data. Regarding visa information, Astex Therapeutics holds a Global Business Mobility visa, specifically a ‘Worker (A rating)’. This suggests the company engages in activities that qualify for this visa category. The company’s core business revolves around biotechnology research and development, as indicated by its stated focus.